本文選題：重復(fù)經(jīng)顱磁刺激 + 精神分裂癥��； 參考：《河北醫(yī)科大學(xué)》2017年碩士論文

【摘要】：目的:對(duì)高頻重復(fù)經(jīng)顱磁刺激(rTMS)改善精神分裂癥陰性癥狀的療效及其影響因素進(jìn)行分析。方法:計(jì)算機(jī)檢索Pubmed、EMbase、Cochrane Library、萬(wàn)方數(shù)據(jù)庫(kù)、CNKI、維普中文期刊數(shù)據(jù)庫(kù)(VIP)以及中國(guó)學(xué)位論文全文數(shù)據(jù)庫(kù)等,收集1997年1月-2016年12月關(guān)于rTMS治療精神分裂癥陰性癥狀的隨機(jī)對(duì)照研究(RCT)。主要的分析指標(biāo)為陽(yáng)性與陰性量表(PANSS)中的陰性癥狀及陰性癥狀量表(SANS)。文獻(xiàn)的篩選、資料的提取和方法學(xué)質(zhì)量評(píng)價(jià)由兩位獨(dú)立的研究者進(jìn)行,并且以RevMan5.3軟件進(jìn)行Meta分析。結(jié)果:1 16篇RCT研究符合入組標(biāo)準(zhǔn),共入組924名患者。其中真刺激組487名患者,偽刺激組437名。2對(duì)比真刺激組和偽刺激治療后的量表評(píng)分發(fā)現(xiàn),兩組之間PANSS-N比較,MD值為-1.39(-2.37至-0.42),有統(tǒng)計(jì)學(xué)差異(Z=2.80,P=0.005);當(dāng)用SANS為評(píng)估指標(biāo),兩組之間結(jié)果發(fā)現(xiàn)MD值為-8.65(-13.11至-4.18),有統(tǒng)計(jì)學(xué)差異(Z=3.80,P=0.001)。3當(dāng)用病程作為亞組分析時(shí)發(fā)現(xiàn)病程小于8年的患者用rTMS治療結(jié)果顯示MD值:-2.00,95%CI:-2.92至-1.08,差異有統(tǒng)計(jì)學(xué)意義(Z=4.27,P0.00001)。4在刺激閾值上,110%的刺激閾值結(jié)果顯示MD值:-13.60,95%CI:-17.08至-10.12,差異有統(tǒng)計(jì)學(xué)意義(Z=7.67,P0.00001)。5在治療病程上,4周的治療療程無(wú)論是用SANS還是PANSS評(píng)定均較其他治療療程效果好,用SANS作為評(píng)估指標(biāo)MD值:-12.90,95%CI:-17.30至-8.51,Z=5.76,P0.00001,用PANSS作為評(píng)估指標(biāo)MD值:-2.06,95%CI:-2.99至-1.12,Z=4.32,P0.0001。6在種族上,中國(guó)人群PANSS-N量表比較,MD值分別為-1.86(95%CI:-2.71至-1.02)差異有統(tǒng)計(jì)學(xué)意義(Z=4.32,P0.00001)。結(jié)論:高頻重復(fù)經(jīng)顱磁刺激輔助治療精神分裂癥陰性癥狀有效,病程時(shí)間越短,治療效果越好。110%的刺激閾值為最佳刺激閾值,治療療程要至少4周以上。與外國(guó)人群相比,中國(guó)人群對(duì)重復(fù)經(jīng)顱磁刺激更為敏感。
[Abstract]:Objective: to analyze the effect of high frequency repetitive transcranial magnetic stimulation (rTMS) on the negative symptoms of schizophrenia. Methods: Pubmedmedus EMbase Cochrane Library, Wanfang database CNKI, VIP database and full text database of Chinese degree papers were searched. The randomized controlled study (RCT) of rTMS in the treatment of schizophrenia negative symptoms from January 1997 to December 2016 was collected. The positive and negative symptom scale (sans) was the main analysis index. Literature screening, data extraction and methodological quality evaluation were carried out by two independent researchers, and Meta-analysis was performed with Revman 5.3 software. Results one hundred and sixteen RCT studies conformed to the admission criteria, involving 924 patients. Of the 487 patients in the true stimulation group and 437 in the pseudo-stimulation group, the scores of PANSS-N were -1.39 (-2.37 to -0.42) in comparison with the true stimulation group and 437 in the pseudo-stimulation group, and there was statistical difference between the two groups (Z _ (2.80) P _ (0.005). The MD value between the two groups was -8.65 (-13.11 to -4.18), and there was statistical difference (ZH3.80 / P0.001) .3 when the course of disease was used as a subgroup analysis, the patients with a course of less than 8 years were treated with rTMS. The results of rTMS showed that the MD value: -2.00 ~ 95CI-2.92 to -1.08, the difference was statistically significant (ZH4.27P0.00001). The stimulation threshold value of 110% showed that the MD value: -13.60,95CI: -17.08 to -10.12, the difference was statistically significant (ZH7.67 P0.00001) .5 in the course of treatment for 4 weeks, both sans and PANSS were better than other courses of treatment. Using sans as the evaluation index, MD: -12.90 / 95CI-17.30 to -8.51a, P 0.00001, using PANSS as the evaluation index, MD: -2.0695 CI: -2.99 to -1.12 ~ 4.32P0.0001.6 in race, the difference of MD between -1.86 (95CIW-2.71 to -1.02) in Chinese population was statistically significant (Z4.32P 0.00001). Conclusion: high frequency repetitive transcranial magnetic stimulation is effective in the treatment of negative symptoms of schizophrenia. The shorter the course of disease is, the better the therapeutic effect is. 110% of the stimulation threshold is the best stimulation threshold, and the course of treatment should be more than 4 weeks. Chinese people are more sensitive to repetitive transcranial magnetic stimulation than foreigners.
【學(xué)位授予單位】：河北醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R749.3

【參考文獻(xiàn)】

相關(guān)期刊論文 前8條

1 徐清;張玉琦;程灶火;;不同重復(fù)經(jīng)顱磁刺激模式對(duì)慢性精神分裂癥陰性癥狀的療效及安全性[J];中國(guó)健康心理學(xué)雜志;2015年08期

2 白莉;甘景梨;梁學(xué)軍;段惠峰;高存友;;重復(fù)經(jīng)顱磁刺激對(duì)精神分裂癥患者彌散張量成像及陰性癥狀的影響[J];中國(guó)健康心理學(xué)雜志;2015年05期

3 王岳鋒;呂斌軍;滕軍波;夏瑛;;重復(fù)經(jīng)顱磁刺激治療對(duì)精神分裂癥陰性癥狀的療效及安全性研究[J];浙江中西醫(yī)結(jié)合雜志;2015年04期

4 甘景梨;段惠峰;程正祥;史振娟;高存友;梁學(xué)軍;祝希泉;趙蘭民;;重復(fù)經(jīng)顱磁刺激對(duì)精神分裂癥難治性陰性癥狀及腦源性神經(jīng)營(yíng)養(yǎng)因子的影響[J];中國(guó)神經(jīng)精神疾病雜志;2014年12期

5 趙素華;孔潔華;李淑玲;童梓順;楊嬋娟;鐘華清;;四種模式的重復(fù)經(jīng)顱磁刺激治療精神分裂癥陰性癥狀的隨機(jī)對(duì)照試驗(yàn)（英文）[J];上海精神醫(yī)學(xué);2014年01期

6 鄭麗娜;郭茜;李惠;李春波;王繼軍;;不同重復(fù)經(jīng)顱磁刺激模式對(duì)精神分裂癥認(rèn)知功能和精神癥狀的影響[J];北京大學(xué)學(xué)報(bào)(醫(yī)學(xué)版);2012年05期

7 吳越;季萍;湯莉;楊國(guó)平;;重復(fù)經(jīng)顱磁刺激對(duì)慢性精神分裂癥陰性癥狀的療效[J];中國(guó)康復(fù);2012年03期

8 任艷萍;周東豐;蔡焯基;黃青;盧苓;陳琦;;高頻重復(fù)經(jīng)顱磁刺激治療精神分裂癥難治性陰性癥狀的隨機(jī)雙盲對(duì)照試驗(yàn)[J];中國(guó)心理衛(wèi)生雜志;2011年02期

，

本文編號(hào)：2073332